K Number
K140039
Device Name
POLYCRYL
Manufacturer
Date Cleared
2014-09-15

(251 days)

Product Code
Regulation Number
878.4493
Panel
SU
Reference & Predicate Devices
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Absorbable Surgical Suture USP/EP is indicated for use in general soft tissue approximation and / or ligation in ophthalmic procedures. The safety and effectiveness of this suture in cardiovascular, neurological and micro surgery have not been established.

Device Description

Not Found

AI/ML Overview

Unfortunately, the provided document does not contain the specific information requested regarding "acceptance criteria and the study that proves the device meets the acceptance criteria." The document is a clearance letter from the FDA for a device called "Polycryl," an absorbable poly(glycolide/L-lactide) surgical suture.

While it mentions that the device is "substantially equivalent" to legally marketed predicate devices, it does not include:

  • A table of acceptance criteria and reported device performance.
  • Details about sample sizes, data provenance, or the number/qualifications of experts for a test set.
  • Information on adjudication methods, MRMC studies, standalone performance, or the type of ground truth used.
  • Details about the training set size or how its ground truth was established.

The document is purely an FDA clearance letter confirming substantial equivalence under a 510(k) pathway, and therefore does not delve into the detailed study results or performance metrics associated with acceptance criteria that would typically be found in a clinical study report or a more comprehensive FDA submission summary.

§ 878.4493 Absorbable poly(glycolide/l-lactide) surgical suture.

(a)
Identification. An absorbable poly(glycolide/l-lactide) surgical suture (PGL suture) is an absorbable sterile, flexible strand as prepared and synthesized from homopolymers of glycolide and copolymers made from 90 percent glycolide and 10 percent l-lactide, and is indicated for use in soft tissue approximation. A PGL suture meets United States Pharmacopeia (U.S.P.) requirements as described in the U.S.P. “Monograph for Absorbable Surgical Sutures;” it may be monofilament or multifilament (braided) in form; it may be uncoated or coated; and it may be undyed or dyed with an FDA-approved color additive. Also, the suture may be provided with or without a standard needle attached.(b)
Classification. Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA.” See § 878.1(e) for the availability of this guidance document.